Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionGladstone Institutional Advisory LLC
Latest Disclosed Ownership5,578 shares
Latest Disclosed Value $ 777,524
Gladstone Institutional Advisory LLC reports 43.00% decrease in ownership of GILD / Gilead Sciences, Inc.

On May 14, 2026 - Gladstone Institutional Advisory LLC filed a 13F-HR form disclosing ownership of 5,578 shares of Gilead Sciences, Inc. (CH:GILD) valued at $777,524 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 9,786 shares of Gilead Sciences, Inc.. This represents a change in shares of -43.00% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F GILEAD SCIENCES COM 375558103 5,578 -4,208 -43.00 778 -35.30 0.0288
2026-02-17 2025-12-31 13F GILEAD SCIENCES COM 375558103 9,786 166 1.73 1,201 12.56 0.0454
2025-10-22 2025-09-30 13F GILEAD SCIENCES COM 375558103 9,620 1,301 15.64 1,068 15.73 0.0411
2025-08-12 2025-06-30 13F GILEAD SCIENCES COM 375558103 8,319 43 0.52 922 -0.54 0.0381
2025-05-15 2025-03-31 13F GILEAD SCIENCES COM 375558103 8,276 4,661 128.93 927 178.38 0.0432
2025-01-29 2024-12-31 13F GILEAD SCIENCES COM 375558103 3,615 -289 -7.40 334 1.83 0.0155
2024-10-28 2024-09-30 13F GILEAD SCIENCES COM 375558103 3,904 -9,014 -69.78 327 -63.09 0.0160
2024-08-02 2024-06-30 13F GILEAD SCIENCES COM 375558103 12,918 182 1.43 886 -4.94 0.0462
2024-05-14 2024-03-31 13F GILEAD SCIENCES COM 375558103 12,736 -819 -6.04 933 -15.12 0.0512
2024-02-09 2023-12-31 13F GILEAD SCIENCES COM 375558103 13,555 -252 -1.83 1,098 6.19 0.0616
2023-11-13 2023-09-30 13F GILEAD SCIENCES COM 375558103 13,807 511 3.84 1,035 0.98 0.0670
2023-08-10 2023-06-30 13F GILEAD SCIENCES COM 375558103 13,296 -97 -0.72 1,025 -7.83 0.0625
2023-05-12 2023-03-31 13F GILEAD SCIENCES COM 375558103 13,393 -2,158 -13.88 1,111 -16.78 0.0720
2023-02-01 2022-12-31 13F GILEAD SCIENCES COM 375558103 15,551 452 2.99 1,335 43.39 0.0942
2023-01-30 2022-09-30 13F/A-1 GILEAD SCIENCES COM 375558103 15,099 1,180 8.48 931 8.26 0.0728
2022-10-20 2022-09-30 13F GILEAD SCIENCES COM 375558103 15,099 1,180 931 0.0728
2023-01-30 2022-06-30 13F/A-1 GILEAD SCIENCES COM 375558103 13,919 1,084 8.45 860 12.71 0.0680
2022-08-15 2022-06-30 13F GILEAD SCIENCES COM 375558103 13,919 1,084 860 0.0680
2023-01-30 2022-03-31 13F/A-1 GILEAD SCIENCES COM 375558103 12,835 1,050 8.91 763 -10.86 0.0516
2022-05-04 2022-03-31 13F GILEAD SCIENCES COM 375558103 12,835 1,050 763 0.0516
2023-01-30 2021-12-31 13F/A-1 GILEAD SCIENCES COM 375558103 11,785 11,785 856 0.0663
2022-02-11 2021-12-31 13F GILEAD SCIENCES COM 375558103 11,785 11,785 856 0.0663
2023-01-28 2020-12-31 13F/A-1 GILEAD SCIENCES COM 375558103 0 -5,204 -100.00 0 -100.00
2021-02-16 2020-12-31 13F GILEAD SCIENCES COM 375558103 0 -5,204 0
2023-01-30 2020-09-30 13F/A-1 GILEAD SCIENCES COM 375558103 5,204 1,497 40.38 329 15.44 0.0786
2020-11-16 2020-09-30 13F GILEAD SCIENCES COM 375558103 5,204 1,497 329 0.0786
2020-08-17 2020-06-30 13F GILEAD SCIENCES COM 375558103 3,707 -4,631 -55.54 285 -54.25 0.0725
2020-05-14 2020-03-31 13F GILEAD SCIENCES COM 375558103 8,338 4,837 138.16 623 174.45 0.1607
2020-02-12 2019-12-31 13F GILEAD SCIENCES COM 375558103 3,501 -497 -12.43 227 -10.28 0.0556
2019-11-13 2019-09-30 13F GILEAD SCIENCES COM 375558103 3,998 3,998 253 0.0643
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.